| ACT VENLAFAXINE XR (37.5 MG) | 02304317 | Marketed | Teva Canada Limited | Mar 2019 |
| ACT VENLAFAXINE XR (75 MG) | 02304325 | Marketed | Teva Canada Limited | Mar 2019 |
| ACT VENLAFAXINE XR (150 MG) | 02304333 | Marketed | Teva Canada Limited | Mar 2019 |
| AURO-VENLAFAXINE XR (37.5 MG) | 02452839 | Marketed | Auro Pharma Inc. | Mar 2016 |
| AURO-VENLAFAXINE XR (75 MG) | 02452847 | Marketed | Auro Pharma Inc. | Mar 2016 |
| AURO-VENLAFAXINE XR (150 MG) | 02452855 | Marketed | Auro Pharma Inc. | Mar 2016 |
| EFFEXOR XR (37.5 MG) | 02237279 | Marketed | BGP Pharma ULC | Aug 2023 |
| EFFEXOR XR (75 MG) | 02237280 | Marketed | BGP Pharma ULC | Aug 2023 |
| EFFEXOR XR (150 MG) | 02237282 | Marketed | BGP Pharma ULC | Aug 2023 |
| M-VENLAFAXINE XR (37.5 MG) | 02471280 | Marketed | Mantra Pharma Inc. | Mar 2026 |
| M-VENLAFAXINE XR (75 MG) | 02471299 | Marketed | Mantra Pharma Inc. | Mar 2026 |
| M-VENLAFAXINE XR (150 MG) | 02471302 | Marketed | Mantra Pharma Inc. | Mar 2026 |
| PMSC-VENLAFAXINE XR (37.5 MG) | 02521466 | Marketed | Pharmascience Inc. | Sep 2022 |
| PMSC-VENLAFAXINE XR (150 MG) | 02521474 | Marketed | Pharmascience Inc. | Aug 2022 |
| PMSC-VENLAFAXINE XR (75 MG) | 02521482 | Marketed | Pharmascience Inc. | Aug 2022 |
| SANDOZ VENLAFAXINE XR (37.5 MG) | 02310317 | Marketed | Sandoz Canada Inc. | Mar 2020 |
| SANDOZ VENLAFAXINE XR (75 MG) | 02310325 | Marketed | Sandoz Canada Inc. | Mar 2020 |
| SANDOZ VENLAFAXINE XR (150 MG) | 02310333 | Marketed | Sandoz Canada Inc. | Mar 2020 |
| TARO-VENLAFAXINE XR (37.5 MG) | 02380072 | Marketed | Sun Pharma Canada Inc. | Oct 2020 |
| TARO-VENLAFAXINE XR (75 MG) | 02380080 | Marketed | Sun Pharma Canada Inc. | Oct 2020 |
| TARO-VENLAFAXINE XR (150 MG) | 02380099 | Marketed | Sun Pharma Canada Inc. | Oct 2020 |
| VENLAFAXINE XR (37.5 MG) | 02339242 | Marketed | Pro Doc Limitee | Apr 2020 |
| VENLAFAXINE XR (75 MG) | 02339250 | Marketed | Pro Doc Limitee | Apr 2020 |
| VENLAFAXINE XR (150 MG) | 02339269 | Marketed | Pro Doc Limitee | Apr 2020 |
| VENLAFAXINE XR (37.5 MG) | 02354713 | Marketed | Sanis Health Inc. | Jan 2023 |
| VENLAFAXINE XR (75 MG) | 02354721 | Marketed | Sanis Health Inc. | May 2023 |
| VENLAFAXINE XR (150 MG) | 02354748 | Marketed | Sanis Health Inc. | Feb 2023 |
| VENLAFAXINE XR (37.5 MG) | 02385929 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2018 |
| VENLAFAXINE XR (75 MG) | 02385937 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2018 |
| VENLAFAXINE XR (150 MG) | 02385945 | Marketed | Sivem Pharmaceuticals Ulc | Jun 2018 |
| VENLAFAXINE XR (37.5 MG) | 02489678 | Marketed | Laboratoire Riva Inc. | Aug 2019 |
| VENLAFAXINE XR (75 MG) | 02489686 | Marketed | Laboratoire Riva Inc. | Aug 2019 |
| VENLAFAXINE XR (150 MG) | 02489694 | Marketed | Laboratoire Riva Inc. | Aug 2019 |
| VENLAFAXINE XR (37.5 MG) | 02516535 | Marketed | JAMP Pharma Corporation | Dec 2021 |
| VENLAFAXINE XR (75 MG) | 02516543 | Marketed | JAMP Pharma Corporation | Jan 2022 |
| VENLAFAXINE XR (150 MG) | 02516551 | Marketed | JAMP Pharma Corporation | Dec 2021 |
| APO-VENLAFAXINE XR (37.5 MG) | 02331683 | Dormant | Apotex Inc. | Jun 2024 |
| APO-VENLAFAXINE XR (75 MG) | 02331691 | Dormant | Apotex Inc. | Jun 2024 |
| APO-VENLAFAXINE XR (150 MG) | 02331705 | Dormant | Apotex Inc. | Sep 2023 |
| BIO-VENLAFAXINE XR (37.5 MG) | 02567555 | Approved | Biomed Pharma | Apr 2026 |
| BIO-VENLAFAXINE XR (75 MG) | 02567563 | Approved | Biomed Pharma | Apr 2026 |
| BIO-VENLAFAXINE XR (150 MG) | 02567571 | Approved | Biomed Pharma | Apr 2026 |
| MAR-VENLAFAXINE XR (37.5 MG) | 02560259 | Approved | Marcan Pharmaceuticals Inc. | Aug 2025 |
| MAR-VENLAFAXINE XR (75 MG) | 02560267 | Approved | Marcan Pharmaceuticals Inc. | Aug 2025 |
| MAR-VENLAFAXINE XR (150 MG) | 02560275 | Approved | Marcan Pharmaceuticals Inc. | Aug 2025 |
| MINT-VENLAFAXINE XR (37.5 MG) | 02522977 | Dormant | Mint Pharmaceuticals Inc | Jul 2026 |
| MINT-VENLAFAXINE XR (75 MG) | 02522985 | Dormant | Mint Pharmaceuticals Inc | Jul 2026 |
| MINT-VENLAFAXINE XR (150 MG) | 02522993 | Dormant | Mint Pharmaceuticals Inc | Jul 2026 |
| NRA-VENLAFAXINE XR (37.5 MG) | 02565544 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-VENLAFAXINE XR (75 MG) | 02565552 | Approved | Nora Pharma Inc. | Feb 2026 |
| NRA-VENLAFAXINE XR (150 MG) | 02565560 | Approved | Nora Pharma Inc. | Feb 2026 |
| PMS-VENLAFAXINE XR (37.5 MG) | 02278545 | Dormant | Pharmascience Inc. | Jul 2024 |
| PMS-VENLAFAXINE XR (75 MG) | 02278553 | Dormant | Pharmascience Inc. | Jul 2024 |
| PMS-VENLAFAXINE XR (150 MG) | 02278561 | Dormant | Pharmascience Inc. | Jul 2024 |
| TEVA-VENLAFAXINE XR (37.5 MG) | 02275023 | Dormant | Teva Canada Limited | Apr 2025 |
| TEVA-VENLAFAXINE XR (75 MG) | 02275031 | Dormant | Teva Canada Limited | Apr 2025 |
| TEVA-VENLAFAXINE XR (150 MG) | 02275058 | Dormant | Teva Canada Limited | Apr 2025 |
| DOM-VENLAFAXINE XR (37.5 MG) | 02299291 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-VENLAFAXINE XR (75 MG) | 02299305 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-VENLAFAXINE XR (150 MG) | 02299313 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| EFFEXOR TABLETS, 37.5MG (37.5 MG) | 02103680 | Cancelled Post Market | Wyeth Canada | Aug 2004 |
| EFFEXOR TABLETS, 50MG (50 MG) | 02103699 | Cancelled Post Market | Wyeth Canada | Aug 2004 |
| EFFEXOR TABLETS, 75MG (75 MG) | 02103702 | Cancelled Post Market | Wyeth Canada | Aug 2004 |
| GD-VENLAFAXINE XR (37.5 MG) | 02360020 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Jul 2018 |
| GD-VENLAFAXINE XR (75 MG) | 02360039 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Jul 2018 |
| GD-VENLAFAXINE XR (150 MG) | 02360047 | Cancelled Post Market | Genmed A Division Of Pfizer Canada Ulc | Jul 2018 |
| MYLAN-VENLAFAXINE XR (37.5 MG) | 02310279 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Feb 2018 |
| MYLAN-VENLAFAXINE XR (75 MG) | 02310287 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Feb 2018 |
| MYLAN-VENLAFAXINE XR (150 MG) | 02310295 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| NTP-VENLAFAXINE XR (37.5 MG) | 02351838 | Cancelled Pre Market | Teva Canada Limited | Jun 2017 |
| NTP-VENLAFAXINE XR (75 MG) | 02351846 | Cancelled Pre Market | Teva Canada Limited | Jun 2017 |
| NTP-VENLAFAXINE XR (150 MG) | 02351854 | Cancelled Pre Market | Teva Canada Limited | Jun 2017 |
| PHL-VENLAFAXINE XR (37.5 MG) | 02299321 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-VENLAFAXINE XR (75 MG) | 02299348 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| PHL-VENLAFAXINE XR (150 MG) | 02299356 | Cancelled Pre Market | Pharmel Inc. | Sep 2017 |
| RIVA-VENLAFAXINE XR (37.5 MG) | 02307774 | Cancelled Post Market | Laboratoire Riva Inc. | Nov 2019 |
| RIVA-VENLAFAXINE XR (75 MG) | 02307782 | Cancelled Post Market | Laboratoire Riva Inc. | Nov 2019 |
| RIVA-VENLAFAXINE XR (150 MG) | 02307790 | Cancelled Post Market | Laboratoire Riva Inc. | Nov 2019 |
| VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (37.5 MG) | 02373858 | Cancelled Pre Market | Dr Reddy's Laboratories Ltd | Jul 2022 |
| VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (75 MG) | 02373866 | Cancelled Pre Market | Dr Reddy's Laboratories Ltd | Jul 2022 |
| VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES (150 MG) | 02373874 | Cancelled Pre Market | Dr Reddy's Laboratories Ltd | Jul 2022 |
| VENLAFAXINE XR (37.5 MG) | 02273969 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| VENLAFAXINE XR (75 MG) | 02273977 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| VENLAFAXINE XR (150 MG) | 02273985 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| VENLAFAXINE XR (37.5 MG) | 02289059 | Cancelled Pre Market | Teva Canada Limited | Oct 2015 |
| VENLAFAXINE XR (75 MG) | 02289067 | Cancelled Pre Market | Teva Canada Limited | Oct 2015 |
| VENLAFAXINE XR (150 MG) | 02289075 | Cancelled Pre Market | Teva Canada Limited | Oct 2015 |
| VENLAFAXINE XR (37.5 MG) | 02344742 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| VENLAFAXINE XR (75.0 MG) | 02344750 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| VENLAFAXINE XR (150.0 MG) | 02344769 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| VENLAFAXINE XR (37.5 MG) | 02367459 | Cancelled Pre Market | Nt Pharma Canada Ltd | Mar 2017 |
| VENLAFAXINE XR (75 MG) | 02367467 | Cancelled Pre Market | Nt Pharma Canada Ltd | Mar 2017 |
| VENLAFAXINE XR (150 MG) | 02367475 | Cancelled Pre Market | Nt Pharma Canada Ltd | Mar 2017 |
| VENLAFAXINE XR (37.5 MG) | 02391392 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Apr 2025 |
| VENLAFAXINE XR (75 MG) | 02391406 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Apr 2025 |
| VENLAFAXINE XR (150 MG) | 02391414 | Cancelled Pre Market | Ranbaxy Pharmaceuticals Canada Inc. | Apr 2025 |